HBHeinrich Betz

Heinrich Betz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Heinrich Betz has a total of 78 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Regulation of postsynaptic gephyrin cluster size by protein phosphatase 1

    by Melanie Bausen, Felix Weltzien, Heinrich Betz, Gregory A. O'Sullivan


  • Supralinear potentiation of NR1/NR3A excitatory glycine receptors by Zn 2+ and NR1 antagonist

    by Christian Madry, Heinrich Betz, Jörg R. P. Geiger, Bodo Laube

    Coassembly of the glycine-binding NMDA receptor subunits NR1 and NR3A results in excitatory glycine receptors of low efficacy. Here, we report that micromolar concentrations of the divalent cation Zn 2+ produce a 10-fold potentiation of NR1/NR3A receptor responses, which resembles that seen upon antagonizing glycine binding to the NR1 subunit. Coapplication of both Zn 2+ and NR1 antagonist caused a supralinear potentiation, resulting in a >120-fold increase of glycine-activated currents. At concentrations >50 μM, Zn 2+ alone generated receptor currents with similar efficacy as glycine, implying that NR1/NR3A receptors can be activated by different agonists. Point mutations in the NR1 and NR3A glycine-binding sites revealed that both the potentiating and agonistic effects of Zn 2+ are mediated by the ligand-binding domain of the NR1 subunit. In conclusion, Zn 2+ acts as a potent positive modulator and agonist at the NR1 subunit of NR1/NR3A receptors. Our results suggest that this unconventional member of the NMDA receptor family may in vivo be gated by the combined action of glycine and Zn 2+ or a yet unknown second ligand.


  • Open Access

    Knock-In Mice Lacking the PDZ-Ligand Motif of mGluR7a Show Impaired PKC-Dependent Autoinhibition of Glutamate Release, Spatial Working Memory Deficits, and Increased Susceptibility to Pentylenetetrazol

    by Chuan-Sheng Zhang, Federica Bertaso, Volker Eulenburg, Mireille Lerner-Natoli, Greta Ann Herin, Liane Bauer, Joel Bockaert, Laurent Fagni, Heinrich Betz, Astrid Scheschonka

    The metabotropic glutamate receptor 7 (mGluR7) is widely expressed throughout the brain and primarily localized at presynaptic active zones, where it is thought to regulate neurotransmitter release. Protein interacting with C kinase 1 (PICK1), a postsynaptic density protein-95/disc-large tumor suppressor protein/zonula occludens-1 (PDZ)-domain protein, binds to the three C-terminal amino acids (-LVI) of the predominant mGluR7 splice variant, mGluR7a, and has been implicated in the synaptic clustering of this receptor. Here, we generated knock-in mice in which the C-terminal LVI coding sequence of exon 10 of the mGluR7 gene was replaced by three alanine codons (-AAA). Immunoprecipitation showed that the PICK1–mGluR7a interaction is disrupted inmGluR7aAAA/AAAmice. However, the synaptic localization of mGluR7a was not altered in cultured hippocampal neurons and brain sections prepared from the knock-in animals. In cerebellar granule cell cultures, the group III mGluR agonistl-AP-4 decreased the frequency of spontaneous excitatory currents in neurons derived from wild-type but notmGluR7aAAA/AAAmice, consistent with the interaction between mGluR7a and PICK1 being required for protein kinase C-mediated inhibition of glutamate release. At the behavioral level, themGluR7aAAA/AAAmice showed no deficits in motor coordination, pain sensitivity, and anxiety but exhibited significant defects in hippocampus-dependent spatial working memory. In addition, they displayed a high susceptibility to the convulsant drug pentylenetetrazole. Together, these results indicate that PICK1 binding to the C-terminal region of mGluR7a is crucial for agonist-triggered presynaptic signalingin vivo.


  • Open Access

    Impaired GABAergic transmission and altered hippocampal synaptic plasticity in collybistin‐deficient mice

    by Theofilos Papadopoulos, Martin Korte, Volker Eulenburg, Hisahiko Kubota, Marina Retiounskaia, Robert J Harvey, Kirsten Harvey, Gregory A O'SUllivan, Bodo Laube, Swen Hülsmann, et al.

    Collybistin (Cb) is a brain‐specific guanine nucleotide exchange factor that has been implicated in plasma membrane targeting of the postsynaptic scaffolding protein gephyrin found at glycinergic and GABAergic synapses. Here we show that Cb‐deficient mice display a region‐specific loss of postsynaptic gephyrin and GABAA receptor clusters in the hippocampus and the basolateral amygdala. Cb deficiency is accompanied by significant changes in hippocampal synaptic plasticity, due to reduced dendritic GABAergic inhibition. Long‐term potentiation is enhanced, and long‐term depression reduced, in Cb‐deficient hippocampal slices. Consistent with the anatomical and electrophysiological findings, the animals show increased levels of anxiety and impaired spatial learning. Together, our data indicate that Cb is essential for gephyrin‐dependent clustering of a specific set of GABAA receptors, but not required for glycine receptor postsynaptic localization.


  • Open Access

    Mass Spectrometric Analysis of Glycine Receptor-associated Gephyrin Splice Variants

    by Ingo Paarmann, Bertram Schmitt, Björn Meyer, Michael Karas, Heinrich Betz


  • Open Access

    Hyperekplexia Phenotype of Glycine Receptor α1 Subunit Mutant Mice Identifies Zn2+ as an Essential Endogenous Modulator of Glycinergic Neurotransmission

    by Klaus Hirzel, Ulrike Müller, A. Tobias Latal, Swen Hülsmann, Joanna Grudzinska, Mathias W. Seeliger, Heinrich Betz, Bodo Laube


  • Open Access

    MacMARCKS interacts with the metabotropic glutamate receptor type 7 and modulates G protein‐mediated constitutive inhibition of calcium channels

    by Federica Bertaso, Yoriko Lill, José M. Airas, Julien Espeut, Jaroslav Blahos, Joël Bockaert, Laurent Fagni, Heinrich Betz, Oussama El Far

    We have previously shown that the interaction of Ca2+/calmodulin with the metabotropic glutamate receptor type 7 (mGluR7) promotes the G‐protein‐mediated inhibition of voltage‐sensitive Ca2+ channels (VSCCs) seen upon agonist activation. Here, we performed a yeast two‐hybrid screen of a new‐born rat brain cDNA library using the cytoplasmic C‐terminal tail of mGluR7 as bait and identified macrophage myristoylated alanine‐rich c‐kinase substrate (MacMARCKS) as a binding protein. The interaction was confirmed in vitro and in vivo by pull‐down assays, immunoprecipitation, and colocalization of mGluR7 and MacMARCKS in transfected HEK293 cells and cultured cerebellar granule cells. Binding of MacMARCKS to mGluR7 was antagonized by Ca2+/calmodulin. In neurons, cotransfection of MacMARCKS with mGluR7, but not mGluR7 mutants unable to bind MacMARCKS, reduced the G‐protein‐mediated tonic inhibition of VSCCs in the absence of mGluR7 agonist. These results suggest that competitive interactions of Ca2+/calmodulin and MacMARCKS with mGluR7 control the tonic inhibition of VSCCs by G‐proteins.


  • Glycine receptors: recent insights into their structural organization and functional diversity

    by Heinrich Betz, Bodo Laube

    Strychnine‐sensitive glycine receptors (GlyRs) are known to mediate synaptic inhibition in spinal cord, brainstem and other regions of the CNS. During the past 5 years, considerable progress has been made in delineating structural determinants of ligand binding and channel activation in recombinant GlyRs. Furthermore, immunohistochemical and gene inactivation studies have disclosed distinct distributions and functions of differentially expressed GlyR subtypes in retina, hippocampus and the dorsal horn of the spinal cord. Accordingly, GlyRs regulate not only the excitability of motor and sensory neurones, but are also essential for the processing of photoreceptor signals, neuronal development and inflammatory pain sensitization. Hence, these receptors constitute promising targets for the development of clinically useful compounds.


  • Glycine transporters: essential regulators of synaptic transmission

    by H. Betz, J. Gomeza, W. Armsen, P. Scholze, V. Eulenburg

    Glycine is a major inhibitory neurotransmitter in the mammalian CNS (central nervous system). Glycinergic neurotransmission is terminated by the uptake of glycine into glycinergic nerve terminals and neighbouring glial cells. This uptake process is mediated by specific Na+/Cl−-dependent GlyTs (glycine transporters), GlyT1 and GlyT2. GlyT1, in addition, is thought to regulate the concentration of glycine at excitatory synapses containing NMDARs (N-methyl-D-aspartate receptors), which require glycine as a co-agonist. We have analysed the physiological roles and regulation of GlyT1 and GlyT2 by generating transporter-deficient mice and searching for interacting proteins. Our genetic results indicate that at glycinergic synapses, the glial transporter GlyT1 catalyses the removal of glycine from the synaptic cleft, whereas GlyT2 is required for the re-uptake of glycine into nerve terminals, thereby allowing for neurotransmitter reloading of synaptic vesicles. Both GlyT1 and GlyT2 are essential for CNS function, as revealed by the lethal phenotypes of the respective knockout mice. Mice expressing only a single GlyT1 allele are phenotypically normal but may have enhanced NMDAR function. GlyT2 is highly enriched at glycinergic nerve terminals, and Ca2+-triggered exocytosis and internalization are thought to regulate GlyT2 numbers in the pre-synaptic plasma membrane. We have identified different interacting proteins that may play a role in GlyT2 trafficking and/or pre-synaptic localization.


  • Top Cited Papers

    GlyR α3: An Essential Target for Spinal PGE 2 -Mediated Inflammatory Pain Sensitization

    by Robert J. Harvey, Ulrike B. Depner, Heinz Wässle, Seifollah Ahmadi, Cornelia Heindl, Heiko Reinold, Trevor G. Smart, Kirsten Harvey, Burkhard Schütz, Osama M. Abo-Salem, et al.

    Prostaglandin E 2 (PGE 2 ) is a crucial mediator of inflammatory pain sensitization. Here, we demonstrate that inhibition of a specific glycine receptor subtype (GlyR α3) by PGE 2 -induced receptor phosphorylation underlies central inflammatory pain sensitization. We show that GlyR α3 is distinctly expressed in superficial layers of the spinal cord dorsal horn. Mice deficient in GlyR α3 not only lack the inhibition of glycinergic neurotransmission by PGE 2 seen in wild-type mice but also show a reduction in pain sensitization induced by spinal PGE 2 injection or peripheral inflammation. Thus, GlyR α3 may provide a previously unrecognized molecular target in pain therapy.